Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Ziyuan Shen, Xing Xing, Kang Rong, Ziyang Geng, Ning Yang, Linyan Xu, Hongfeng Ge, Wei Sang · 2026
Read Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients by Ziyuan Shen, Xing Xing, Kang Rong, Ziyang Geng, Ning Yang, Linyan Xu, Hongfeng Ge, Wei Sang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13142727.txt.
Description
Ziyuan Shen and seven co-authors track gut bacteria week by week as lymphoma patients receive CAR-T cell treatment, in a two thousand twenty-six microbiome study. Gut microbes may tune the engineered immune cells' performance.
By week two after the cells went in, Bacteroidota had risen greatly while the Firmicutes-to-Bacteroidota ratio fell. Genera including Parabacteroides and Prevotella bloomed, taking the place of starting Clostridium and Fusobacterium signatures. Lipoic acid metabolism pathways that models pointed to switched on at weeks one and two. The blooming genera rose and fell with lymphocyte counts and moved opposite to the inflammation marker C-reactive protein. The authors propose these shifts as early microbe signs for tracking immune modulation.
Catalog record
| CREATOR | Ziyuan Shen, Xing Xing, Kang Rong, Ziyang Geng, Ning Yang, Linyan Xu, Hongfeng Ge, Wei Sang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |